What they were paid
Oruka Therapeutics Director Compensation Table · the one fiscal year held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $3,423 | — | $800,527 | — | $803,950 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Oruka Therapeutics, Inc. DEF 14A filed April 17, 2026, accession 0001213900-26-045159, and prior-year filings. Open the filing on EDGAR.
How this board is paid
company policy · FY2025Oruka Therapeutics pays directors a $40,000 cash retainer.
Committees
FY2025 · as the proxy prints themAudit · Compensation
The rest of the Oruka Therapeutics board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Carl Dambkowski | Independent Director | $200,567 |
| Kristine Ball | Independent Director | $213,067 |
| Lawrence Klein | Director | $0 |
| Peter Harwin | Independent Director | $209,067 |
| Samarth Kulkarni | Independent Director | $234,067 |
The full Oruka Therapeutics compensation record
free company briefThis page is one director within Oruka Therapeutics's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat